Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Wendy Carruthers, EVP of Human Resources at Boston Scientific, exercised stock options and sold shares of common stock under a pre-established Rule 10b5-1 trading plan.
Summary
- Wendy Carruthers, EVP of Human Resources at Boston Scientific, filed a Form 4 detailing changes in beneficial ownership.
- On August 1, 2024, Carruthers exercised stock options to acquire 3,066 shares at $17.26 and 1,197 shares at $24.55.
- Also on August 1, 2024, Carruthers sold 6,983 shares of common stock at $74.12.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
- Following these transactions, Carruthers directly owns 40,188 shares of Boston Scientific common stock and holds options to purchase 30,235 additional shares.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on current market information, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on current market information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares, but the pre-planned nature of the transactions mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| November 17, 2023 | Date of adoption of the Rule 10b5-1 trading plan |
| August 1, 2024 | Date of stock option exercise and stock sale |
| February 22, 2017 | First anniversary of the grant date for 3,066 stock options |
| February 28, 2018 | First anniversary of the grant date for 1,197 stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.